A detailed history of National Asset Management, Inc. transactions in Omeros Corp stock. As of the latest transaction made, National Asset Management, Inc. holds 15,380 shares of OMER stock, worth $62,442. This represents 0.0% of its overall portfolio holdings.

Number of Shares
15,380
Previous 14,380 6.95%
Holding current value
$62,442
Previous $47,000 12.77%
% of portfolio
0.0%
Previous 0.0%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 16, 2024

BUY
$2.88 - $4.89 $2,880 - $4,890
1,000 Added 6.95%
15,380 $53,000
Q4 2023

Mar 15, 2024

SELL
$1.08 - $3.63 $1,080 - $3,630
-1,000 Reduced 6.5%
14,380 $47,000
Q4 2022

Mar 15, 2023

SELL
$1.75 - $3.96 $3,325 - $7,524
-1,900 Reduced 11.0%
15,380 $34,000
Q4 2022

Feb 21, 2023

BUY
$1.75 - $3.96 $3,325 - $7,524
1,900 Added 12.35%
17,280 $39,000
Q3 2022

Nov 14, 2022

SELL
$3.09 - $7.46 $889 - $2,148
-288 Reduced 1.84%
15,380 $49,000
Q2 2022

Aug 12, 2022

BUY
$1.92 - $6.28 $192 - $628
100 Added 0.64%
15,668 $44,000
Q1 2022

May 02, 2022

SELL
$5.07 - $7.2 $16,391 - $23,277
-3,233 Reduced 17.2%
15,568 $94,000
Q4 2021

Jan 28, 2022

BUY
$5.67 - $8.54 $1,043 - $1,571
184 Added 0.99%
18,801 $121,000
Q3 2021

Nov 16, 2021

BUY
$13.4 - $16.3 $6,700 - $8,150
500 Added 2.76%
18,617 $257,000
Q2 2021

Aug 10, 2021

BUY
$14.81 - $19.13 $27,887 - $36,021
1,883 Added 11.6%
18,117 $269,000
Q1 2021

May 13, 2021

SELL
$14.52 - $23.53 $21,518 - $34,871
-1,482 Reduced 8.37%
16,234 $289,000
Q4 2020

Feb 04, 2021

BUY
$10.14 - $15.19 $20,969 - $31,412
2,068 Added 13.22%
17,716 $254,000
Q3 2020

Nov 09, 2020

BUY
$9.57 - $21.32 $9,952 - $22,172
1,040 Added 7.12%
15,648 $159,000
Q2 2020

Jul 31, 2020

BUY
$12.21 - $16.99 $2,881 - $4,009
236 Added 1.64%
14,608 $216,000
Q1 2020

May 06, 2020

SELL
$9.03 - $19.72 $43,524 - $95,050
-4,820 Reduced 25.11%
14,372 $193,000
Q4 2019

Feb 10, 2020

BUY
$13.01 - $17.15 $5,204 - $6,859
400 Added 2.13%
19,192 $271,000
Q3 2019

Nov 12, 2019

BUY
$14.55 - $20.56 $88,318 - $124,799
6,070 Added 47.71%
18,792 $307,000
Q2 2019

Aug 05, 2019

SELL
$15.0 - $19.62 $6,870 - $8,985
-458 Reduced 3.47%
12,722 $200,000
Q1 2019

May 08, 2019

SELL
$11.65 - $17.72 $23,300 - $35,440
-2,000 Reduced 13.18%
13,180 $229,000
Q4 2018

Feb 08, 2019

BUY
$10.72 - $16.73 $26,800 - $41,825
2,500 Added 19.72%
15,180 $170,000
Q3 2018

Nov 08, 2018

SELL
$17.73 - $26.69 $12,588 - $18,949
-710 Reduced 5.3%
12,680 $310,000
Q2 2018

Oct 05, 2018

BUY
$10.79 - $24.44 $1,079 - $2,444
100 Added 0.75%
13,390 $243,000
Q1 2018

May 15, 2018

BUY
$9.0 - $20.16 $6,615 - $14,817
735 Added 5.85%
13,290 $149,000
Q4 2017

Feb 15, 2018

BUY
$13.26 - $22.86 $23,735 - $40,919
1,790 Added 16.63%
12,555 $244,000
Q3 2017

Nov 13, 2017

BUY
$19.76 - $24.9 $212,716 - $268,048
10,765
10,765 $233,000

Others Institutions Holding OMER

About OMEROS CORP


  • Ticker OMER
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 62,730,000
  • Market Cap $255M
  • Description
  • Omeros Corporation, a commercial-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule and protein therapeutics, and orphan indications targeting inflammation, complement-mediated diseases, cancers related to dysfunction of the immune system, and addictive and compulsive disorders. The company's clinical program...
More about OMER
Track This Portfolio

Track National Asset Management, Inc. Portfolio

Follow National Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of National Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on National Asset Management, Inc. with notifications on news.